Related Experiment Video

Updated: Jul 6, 2026

Pipeline for Planning and Execution of Transcranial Ultrasound Neuromodulation Experiments in Humans
07:52

Pipeline for Planning and Execution of Transcranial Ultrasound Neuromodulation Experiments in Humans

Published on: June 28, 2024

Transcranial ultrasound in Parkinson's disease

Matthew B Stern

    The Lancet. Neurology
    |April 9, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Methodological Protocol and Considerations for Transcranial Ultrasonic Stimulation in Exploratory Clinical Human Studies
    09:47

    A Methodological Protocol and Considerations for Transcranial Ultrasonic Stimulation in Exploratory Clinical Human Studies

    Published on: December 12, 2025

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
    05:54

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

    Published on: December 13, 2017

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Pipeline for Planning and Execution of Transcranial Ultrasound Neuromodulation Experiments in Humans
    07:52

    Pipeline for Planning and Execution of Transcranial Ultrasound Neuromodulation Experiments in Humans

    Published on: June 28, 2024

    A Methodological Protocol and Considerations for Transcranial Ultrasonic Stimulation in Exploratory Clinical Human Studies
    09:47

    A Methodological Protocol and Considerations for Transcranial Ultrasonic Stimulation in Exploratory Clinical Human Studies

    Published on: December 12, 2025

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
    05:54

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

    Published on: December 13, 2017

    Related Concept Videos

    Parkinson's Disease: Treatment01:24

    Parkinson's Disease: Treatment

    Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
    Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

    Articles linked to this work by shared authors, journal, and citation graph.

    Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?

    Movement disorders clinical practice·2018

    Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers.

    Movement disorders clinical practice·2018

    Cognition and the course of prodromal Parkinson's disease.

    Movement disorders : official journal of the Movement Disorder Society·2017

    Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.

    Annals of clinical and translational neurology·2016

    Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.

    Movement disorders : official journal of the Movement Disorder Society·2015

    Natural history of multiple system atrophy in the USA: a prospective cohort study.

    The Lancet. Neurology·2015

    Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis.

    The Lancet. Neurology·2026

    Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

    The Lancet. Neurology·2026

    Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities.

    The Lancet. Neurology·2026

    Advances in chronic subdural haematoma management: beyond the burr hole.

    The Lancet. Neurology·2026

    Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study.

    The Lancet. Neurology·2026

    Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis.

    The Lancet. Neurology·2026

    Infra-clavicular approach to posterior cord brachial plexus schwannoma.

    Surgical neurology international·2026

    Cerebellar Degeneration Causing Saccadic Dysmetria and Ocular Flutter: A Seronegative Paraneoplastic Syndrome.

    Neuro-ophthalmology (Aeolus Press)·2026

    Effect of Intracoronary Recombinant Human Prourokinase on Myocardial Perfusion and Clinical Outcomes in STEMI Patients Undergoing Primary PCI: A Randomized Controlled Trial.

    Reviews in cardiovascular medicine·2026

    New-Onset Pain and Neurologic Deficit After Intraoperatively Uneventful Lumbar Spine Surgery: A Prospective Observational Case Series and Proposed Management Algorithm.

    Cureus·2026

    Nicotine Exposure During Gestation: From Placental Dysfunction to Long-Term Neurobehavioral Outcomes.

    Birth defects research·2026

    Adipose tissue plays a crucial role in obesity-induced postoperative neurocognitive disorders.

    Journal of translational medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us